Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 14 OTHER_GOV 2 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Genetic Diseases, Inborn 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 39 Docetaxel 30 Tamoxifen 29 Paclitaxel 27 Doxorubicin 26 Trastuzumab 20 Radiotherapy 18 Epirubicin 16 Letrozole 13 exemestane 11 Fluorouracil 11 Anastrozole 11 Capecitabine 10 Bevacizumab 10 Immunohistochemistry 9 Filgrastim 9 Fulvestrant 8 Methotrexate 7 Gene Expression Profiling 7 palbociclib 6 Zoledronic Acid 6 Microarray Analysis 6 Lapatinib 6 Goserelin 6 Chemotherapy, Adjuvant 6 Amplified Fragment Length Polymorphism Analysis 6 Vinorelbine 5 Triptorelin Pamoate 5 Carboplatin 5 Absorptiometry, Photon 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Breast Neoplasms × Tablets × Clear all

NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting

Breast Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡